Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,375 | -88,612 | -265,939 | -201,285 | -131,867 |
| Depreciation Amortization | 3,134 | 1,283 | 4,323 | 3,076 | 2,007 |
| Accounts receivable | 389 | 6,303 | 1,738 | 1,620 | 1,976 |
| Accounts payable and accrued liabilities | 3,915 | 3,719 | -887 | 466 | 1,738 |
| Other Working Capital | -3,998 | 962 | 7,710 | 9,811 | 6,083 |
| Other Operating Activity | 30,670 | 10,352 | 48,172 | 35,678 | 20,154 |
| Operating Cash Flow | $-133,265 | $-65,993 | $-204,883 | $-150,634 | $-99,909 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,029 | -4,662 | -11,880 | -9,041 | -3,048 |
| Investing Cash Flow | $-8,029 | $-4,662 | $-11,880 | $-9,041 | $-3,048 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,875 | 294 | 561,721 | 112,345 | 101,989 |
| Financing Cash Flow | $2,875 | $294 | $561,721 | $112,345 | $101,989 |
| Beginning Cash Position | 738,674 | 738,674 | 393,716 | 393,716 | 393,716 |
| End Cash Position | 600,255 | 668,313 | 738,674 | 346,386 | 392,748 |
| Net Cash Flow | $-138,419 | $-70,361 | $344,958 | $-47,330 | $-968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -133,265 | -65,993 | -204,883 | -150,634 | -99,909 |
| Capital Expenditure | -8,029 | -4,662 | -12,010 | -9,171 | -3,178 |
| Free Cash Flow | -141,294 | -70,655 | -216,893 | -159,805 | -103,087 |